发明名称 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
摘要 The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Heat shock 70 kDa protein 1, Alpha-1-antitrypsin Neutrophil elastase complex, Stromelysin-1:Metalloproteinase inhibitor 2 complex, 72 kDa type IV collagenase:Metalloproteinase inhibitor 2 complex, Insulin-like growth factor 1 receptor, Myeloid differentiation primary response protein MyD88, Neuronal cell adhesion molecule, and Tumor necrosis factor ligand superfamily member 10 as diagnostic and prognostic biomarkers in renal injuries.
申请公布号 US2014213477(A1) 申请公布日期 2014.07.31
申请号 US201214241005 申请日期 2012.08.24
申请人 ASTUTE MEDICAL, INC. 发明人 Anderberg Joseph;Gray Jeff;Mcpherson Paul;Nakamura Kevin;Kampf James Patrick
分类号 G01N33/68 主分类号 G01N33/68
代理机构 代理人
主权项 1. A method for evaluating renal status in a subject, comprising: performing one or more assays configured to detect one or more biomarkers selected from the group consisting of Heat shock 70 kDa protein 1, Alpha-1-antitrypsin Neutrophil elastase complex, Stromelysin-1:Metalloproteinase inhibitor 2 complex, 72 kDa type IV collagenase:Metalloproteinase inhibitor 2 complex, Insulin-like growth factor 1 receptor, Myeloid differentiation primary response protein MyD88, Neuronal cell adhesion molecule, and Tumor necrosis factor ligand superfamily member 10 on a body fluid sample obtained from the subject to provide an assay result; and correlating the assay result(s) to the renal status of the subject.
地址 San Diego CA US